Visual electrophysiology company LKC Technologies reported on Friday the launch of its partnership with US Retina, one of the largest associations of private retina practices in the US with 203 member practices representing over 1,000 physicians, Group Purchasing Organisation (GPO).
US Retina reportedly provides valuable and immediate access to LKC's new technologies to advance the former's quality patient care, according to Peter L. Sonkin, MD, US Retina Board Member and Retinal Specialist at Tennessee Retina.
Helping the way physicians detect, diagnose and treat vision threatening diseases is the goal of every US Retina's retinal physician and LKC Technologies is the perfect partner to help US Retina's members gain access to high quality electrodiagnostic devices wherever they practice, added Dr L. Sonkin.
LKC is developing systems to provide objective functional information assisting in effective diagnosis of many ophthalmic conditions and vision threatening diseases. US Retina's vision is to lead the Retinal Vitreous industry toward high-quality and cost-effective healthcare, creating outcomes that exceed the expectations of its members, partners and patients.
QT Imaging signs exclusive USD33m distribution deal with Gulf Medical in Saudi Arabia
Novocure submits FDA PMA for Tumor Treating Fields therapy in pancreatic cancer
Covalon Technologies secures DTC eligibility to expand US investor access
Navamedic ASA secures final approvals for Flexilev in OraFID across Nordic markets
Oncopeptides partners with SD Pharma to expand Pepaxti access in Spain
Aptar launches bio-based nasal spray pump with Haleon's Otrivin brand
MAP Medical agrees distribution deal with Metrix-Secure
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Alcon to acquire LumiThera and its FDA-authorised photobiomodulation device for dry AMD treatment
Predictmedix AI launches mobile diabetes screening platform in India
Navamedic's medical device OraFID approved as primary package for a pharmaceutical product
Speranza Therapeutics partners with Sunshine Labs for harm reduction solutions
Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement